Condor Capital Management’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Condor Capital Management’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,300	Closed	-$13K	–	416
2022 Q3	$13K	Buy	+1,300	New	+$12.9K	﹤0.01%	400
2022 Q2	–	Sell	-1,020	Closed	-$10K	–	494
2022 Q1	$10K	Hold	1,020	–	–	﹤0.01%	403
2021 Q4	$10K	Hold	1,020	–	–	﹤0.01%	365
2021 Q3	$10K	Hold	1,020	–	–	﹤0.01%	294
2021 Q2	$10K	Buy	+1,020	New	+$10.2K	﹤0.01%	281

Other funds holding EBACU

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

TAM

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Condor Capital Management's EBACU Position: Q4 2022 in Review

Condor Capital Management sold out of European Biotech Acquisition Corp. Units (EBACU) in Q4 2022, closing a stake of 1,300 shares — an estimated $13K sold.

Condor Capital Management first reported a position in EBACU in Q2 2021 and held it in 5 quarters. The position peaked at $13K in Q3 2022. 11 funds tracked by Wall St. Rank hold EBACU as of Q4 2022.

Condor Capital Management reported no remaining European Biotech Acquisition Corp. Units position as of Q4 2022 after selling out during the quarter.
Condor Capital Management sold 1,300 European Biotech Acquisition Corp. Units shares in Q4 2022, an estimated $13K.
Condor Capital Management first reported a position in European Biotech Acquisition Corp. Units in Q2 2021 and held it in 5 quarters.
Condor Capital Management's European Biotech Acquisition Corp. Units position peaked at $13K in Q3 2022.
11 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q4 2022.

Based on Condor Capital Management's 13F filing for Q4 2022, filed 7 Feb 2023.